You may also like
Molecular Mechanisms of Heparin-Induced Platelet Dysfunction
Introduction Hemostasis involves many components, all of which must function properly in order for the process to be efficient. Maintaining adequate hemostasis […]
8 min read
Plasma-Modified ACT Can Be Used to Monitor Bivalirudin (Angiomax) Anticoagulation for On-Pump Cardiopulmonary Bypass Surgery in a Patient with Heparin-Induced Thrombocytopenia
We report here the successful use of bivalirudin anticoagulation on pump, with no additional morbidity, and the first reported use of the plasma-modified ACT (activated clotting time) test, a simple modification of the standard ACT assay, to monitor the anticoagulant effect of bivalirudin.
1 min read
Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients.
1 min read
